National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 45003 [2024-11187]
Download as PDF
<![CDATA[
45003
Federal Register / Vol. 89, No. 100 / Wednesday, May 22, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Information collection forms
PHS 398 Career Development Award Supplemental Form ............................
PHS Human Subjects and Clinical Trial Information .......................................
Biosketch (424 Electronic) ...............................................................................
Data Management and Sharing Plan ..............................................................
Average
burden per
response
(in hours)
Number of
responses per
respondent
2,251
54,838
80,946
73,117
Total annual
burden hours
1
1
1
1
10
13
2
2
22,510
712,894
161,892
146,234
6,707
6,707
29
6,707
6,217
6
1,500
1
1
1
1
1
1
1
13
2
10
5/60
5/60
5/60
15/60
87,191
13,414
290
559
518
1
375
239
........................
1
486,749
11
........................
2,629
2,175,670
PHS Fellowship—Electronic
PHS Fellowship Supplemental Form (includes F reference letters) ...............
Biosketch (Fellowship) .....................................................................................
416–1 ...............................................................................................................
PHS 416–5 ......................................................................................................
PHS 6031 ........................................................................................................
VCOC Certification ..........................................................................................
SBIR/STTR Funding Agreement Certification .................................................
NIH Other Transaction
NIH Other Transaction Application Form ........................................................
Total Annual Burden Hours ......................................................................
Dated: May 13, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–11251 Filed 5–21–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; HEAL Initiative: Nonaddictive Analgesic Therapeutics
Development [Small Molecules and
Biologics] to Treat Pain.
Date: June 17, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
VerDate Sep<11>2014
17:06 May 21, 2024
Jkt 262001
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: W. Ernest Lyons, Ph.D.,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Activities, NINDS/NIH/DHHS, NSC, 6001
Executive Boulevard, Rockville, MD 20852,
301–496–4056, lyonse@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: May 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–11187 Filed 5–21–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health (NIH)
Office of Science Policy (OSP):
Request for Information on Draft NIH
Intramural Research Program Policy:
Promoting Equity Through Access
Planning
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Institutes of
Health (NIH) is proposing to develop
and implement a new policy within its
Intramural Research Program (IRP) to
promote access to products stemming
SUMMARY:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
from taxpayer-funded inventions. NIH
seeks input on this draft policy and
accompanying draft license agreement
language that incorporates patient
access in the commercialization process
for NIH-owned inventions.
DATES: To ensure consideration,
comments must be submitted in writing
by July 22, 2024.
ADDRESSES: Comments may be
submitted electronically to Https://osp.
od.nih.gov/comment-form-draft-nihintramural-research-program-policypromoting-equity-through-accessplanning/. Responses to this request for
information are voluntary and may be
submitted anonymously. You may
voluntarily include your name and
contact information with your response.
Other than your name and contact
information, please do not include in
the response any personally identifiable
information or any information that you
do not wish to make public. Proprietary,
classified, confidential, or sensitive
information should not be included in
your response. After the Office of
Science Policy (OSP) has finished
reviewing the responses, the responses
may be posted to the OSP website
without redaction.
FOR FURTHER INFORMATION CONTACT:
Abby Rives, Director of the Technology
Transfer and Innovation Policy, at (301)
496–9838 or SciencePolicy@od.nih.gov.
SUPPLEMENTARY INFORMATION:
Background
As the world’s largest public funder of
biomedical research, NIH seeks to drive
effective partnerships that foster a
shared commitment to transforming
E:\FR\FM\22MYN1.SGM
22MYN1
]]>Agencies
[Federal Register Volume 89, Number 100 (Wednesday, May 22, 2024)]
[Notices]
[Page 45003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11187]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; HEAL Initiative: Non-addictive
Analgesic Therapeutics Development [Small Molecules and Biologics]
to Treat Pain.
Date: June 17, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: W. Ernest Lyons, Ph.D., Scientific Review
Administrator, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Boulevard,
Rockville, MD 20852, 301-496-4056, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS).
Dated: May 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-11187 Filed 5-21-24; 8:45 am]
BILLING CODE 4140-01-P
